Side-by-side comparison

ABBV vs TMO — Side-by-side comparison

ABBV screens cheaper on EV/FCF, TMO has the higher ROIC, TMO has grown revenue faster over five years, and TMO has the cleaner balance sheet by net debt / EBITDA.

ABBV

AbbVie Inc.

Price

$215.70

Market cap

$346.8B

Day %

N/A

TMO

Thermo Fisher Scientific

Price

$448.28

Market cap

$159.4B

Day %

N/A

Peer Comparison

Target stock against 1 market-cap comparable peer.

Heat map: red worst to green best


ABBV Target	AbbVie Inc.	$346.8B	91.4x	22.8x	6.9%	6.0%	29.1%	N/A	3.7x	N/A
TMO	Thermo Fisher Scientific	$159.4B	25.3x	30.0x	7.3%	6.7%	14.1%	N/A	3.3x	N/A

ABBV implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

22.8x

FCF yield

5.1%

5Y rev CAGR

6.0%

TMO implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

30.0x

FCF yield

3.9%

5Y rev CAGR

6.7%

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for ABBV.

Grade C

/ 100

Quality Scorecard

Build-time composite score for TMO.

Grade C

/ 100